March 11, 2019
The Ohio State University College of Pharmacy is pleased to present distinguished lecturer Calvin H. Knowlton, BScPharm, MDiv, PhD, on Wednesday, April 3, 2019, at 11:30 a.m. in 103 Parks Hall. Knowlton’s talk, “A Novel Approach to Medication Safety: Backed by Science, Proven Outcomes, and Documented Savings,” is part of the 2019 Milap Nahata Distinguished Lecture series.
Knowlton is the co-founder, chairperson and CEO of Tabula Rasa HealthCare (TRHC), the first national Medication Risk Mitigation company. Since its founding in 2009, TRHC has become the leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Knowlton took TRHC public in September of 2016.
Knowlton received numerous awards for leadership in pharmacy, business and philanthropy in his 30-year career, including the 2003 and 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2016 Philadelphia Technology CEO of the Year Award. He received the American Pharmacists Association’s Remington Honor Medal in 2015, the profession of pharmacy’s highest honor. Knowlton served as the national president for the American College of Apothecaries, president of the American Pharmacists Association for two terms and president of the American Pharmacists Association Foundation. He also served on numerous boards.
Prior to serving as a professor and department chair for the University of Sciences in Philadelphia in the 1990s, Knowlton received his pharmacy degree from Temple University. He received a divinity degree from Princeton Theological Seminary and his PhD in pharmacoeconomics from the University of Maryland.
The Nahata Lectureship was developed to invite and honor a distinguished scholar and leader who can inspire the college’s faculty, residents, fellows, students and alumni to advance clinical pharmacy education, research and practice. The lectureship was established in recognition of Nahata’s outstanding and sustained contributions to clinical pharmacy.